Clinical Trials and Research Studies

At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.

Recently Added/Updated Trials

  • A Phase II Multicenter Double-Blind Randomised Placebo-Controlled Study and Open-Label Long Term Extension to Evaluate the Safety and Efficacy of Elafibranor in Adult Participants with Primary Sclerosing Cholangitis (PSC)

    This study will evaluate the effects of elafibranor (the study drug) in participants with Primary Sclerosing Cholangitis (PSC). PSC is a rare disease of the ...

    View Details

  • International study of Artificial Intelligence-based Diagnosis of Cardiomyopathy using Cardiac MRI

    This study is testing the ability of artificial intelligence-based algorithms to look at cardiac MRI images to: i) decide what disease a patient has, and ...

    View Details

  • Early Signs: digital phenotyping to identify digital biomarkers for predicting burnout and cognitive functioning in ED clinicians

    We are looking for participants for a prospective research study titled "Early Signs: digital phenotyping to identify digital biomarkers for predicting burnout and cognitive functioning ...

    View Details

  • A Pilot Phase II Open-Label Single-Center Study of Sodium-Glucose Cotransporter-2 Inhibitor Empagliflozin in Major Depressive Disorder

    The purpose of this research study is to test whether empagliflozin, a medication part of a group known as sodium-glucose cotransporter-2 inhibitors (SGLT2) inhibitors, might ...

    View Details

  • A Phase I First-in-human Open-label Multicenter Study to Investigate the Safety Tolerability Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants with Advanced Solid Tumors

    This is a medical study for people with advanced solid tumors who haven't benefited from or can't have standard treatment. The study has ...

    View Details

  • A PHASE 3 TRIAL OF FIANLIMAB (ANTI-LAG-3) AND CEMIPLIMAB VERSUS PEMBROLIZUMAB IN THE ADJUVANT SETTING IN PATIENTS WITH COMPLETELY RESECTED HIGH-RISK MELANOMA

    This is a phase 3 clinical trial that compares the effectiveness of two different treatment options in patients who have undergone surgery to remove high-risk ...

    View Details

  • Optimized sodium MR imaging in mild traumatic brain injury

    Conventional imaging studies (CT scans or MRI) are oftentimes normal, leaving individuals with an injury that is difficult to detect, difficult to predict the outcome ...

    View Details

  • A pilot proof of concept study of the Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate Responders (EASi-RAIR)

    The purpose of this research is to study Short Chain Fatty Acids (SCFAs), bacterial fermentation products that are naturally found at varying concentrations in your ...

    View Details